The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-ethyl 6-chloro-3-((2-(3-(dimethylamino)propanoyl)hydrazono)methyl)-1H-indole-2-carboxylate ID: ALA4474467
PubChem CID: 155537062
Max Phase: Preclinical
Molecular Formula: C17H21ClN4O3
Molecular Weight: 364.83
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1/C=N/NC(=O)CCN(C)C
Standard InChI: InChI=1S/C17H21ClN4O3/c1-4-25-17(24)16-13(10-19-21-15(23)7-8-22(2)3)12-6-5-11(18)9-14(12)20-16/h5-6,9-10,20H,4,7-8H2,1-3H3,(H,21,23)/b19-10+
Standard InChI Key: GMEAECFBAROULJ-VXLYETTFSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.2817 -19.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2805 -20.0179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9953 -20.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9935 -18.7778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7088 -19.1869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7137 -20.0133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5011 -20.2641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9830 -19.5927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4933 -18.9270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5658 -20.4297 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.7436 -18.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5495 -17.9647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7998 -17.1786 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6057 -17.0024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8560 -16.2164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8080 -19.5878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2246 -20.2998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2162 -18.8710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0495 -20.2950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4663 -21.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1613 -17.6122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9672 -17.4360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5228 -18.0458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3288 -17.8695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2725 -18.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
8 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 1 0
14 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.83Molecular Weight (Monoisotopic): 364.1302AlogP: 2.40#Rotatable Bonds: 7Polar Surface Area: 86.79Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.03CX Basic pKa: 9.08CX LogP: 1.90CX LogD: 0.48Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -1.58
References 1. van der Vlag R, Guo H, Hapko U, Eleftheriadis N, Monjas L, Dekker FJ, Hirsch AKH.. (2019) A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1., 174 [PMID:31026746 ] [10.1016/j.ejmech.2019.04.021 ]